Sunday, October 13, 2019 9:45:51 PM
Also show the percentage of these companies that are involved in the cultivation, aggregation, and manufacturing and processing of the high CBD hemp into isolate, and not just reselling cbd isolate (such as Marathon Rx with rebranded Canbiola CBD isolate)
Also do these 1000+ companies have a Duramed subsidiary of Canbiola with a proprietary SAM and TENS units containing CBD isolate pads?
https://duramed.us/
Recent CANB News
- Can B Corp. Secures Ownership and Control of Two Cannabis Patents Valued at $122 Million and Potentially in Excess of $750 Million • InvestorsHub NewsWire • 03/11/2024 12:34:14 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/06/2024 10:15:42 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/01/2024 10:02:41 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 09:38:08 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 04:52:26 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 02/08/2024 06:08:58 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/16/2024 12:52:36 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/26/2023 03:36:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2023 10:15:27 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 09:18:08 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/13/2023 02:44:53 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/03/2023 06:24:08 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/10/2023 08:57:21 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/21/2023 09:12:43 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/14/2023 08:41:28 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM